Bayer (BAYN) PT Set at €69.00 by Warburg Research

Share on StockTwits

Bayer (FRA:BAYN) has been assigned a €69.00 ($80.23) price objective by research analysts at Warburg Research in a research note issued to investors on Wednesday. The firm presently has a “neutral” rating on the healthcare company’s stock. Warburg Research’s target price points to a potential upside of 12.60% from the stock’s current price.

Other analysts have also recently issued research reports about the stock. Independent Research set a €69.00 ($80.23) price objective on shares of Bayer and gave the stock a “neutral” rating in a report on Thursday, December 6th. Sanford C. Bernstein set a €88.00 ($102.33) price objective on shares of Bayer and gave the stock a “buy” rating in a report on Wednesday, January 2nd. Barclays set a €80.00 ($93.02) price objective on shares of Bayer and gave the stock a “buy” rating in a report on Monday, February 25th. JPMorgan Chase & Co. set a €70.00 ($81.40) price objective on shares of Bayer and gave the stock a “neutral” rating in a report on Friday, March 1st. Finally, equinet set a €96.00 ($111.63) price objective on shares of Bayer and gave the stock a “buy” rating in a report on Tuesday, November 27th. Nine equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of €87.83 ($102.12).

BAYN stock opened at €61.28 ($71.26) on Wednesday. Bayer has a twelve month low of €91.58 ($106.49) and a twelve month high of €123.82 ($143.98).

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Featured Article: What is the Bid-Ask Spread?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nordea Investment Management AB Lowers Position in AutoZone, Inc.
Nordea Investment Management AB Lowers Position in AutoZone, Inc.
Redmile Group LLC Sells 2,034 Shares of LHC Group, Inc.
Redmile Group LLC Sells 2,034 Shares of LHC Group, Inc.
Redmile Group LLC Acquires 2,179,160 Shares of ImmunoGen, Inc.
Redmile Group LLC Acquires 2,179,160 Shares of ImmunoGen, Inc.
F.N.B. Corp  Given Average Recommendation of “Hold” by Brokerages
F.N.B. Corp Given Average Recommendation of “Hold” by Brokerages
Insider Buying: Total Energy Services Inc  Insider Purchases 4,000 Shares of Stock
Insider Buying: Total Energy Services Inc Insider Purchases 4,000 Shares of Stock
Tolar Reaches Market Capitalization of $2.32 Million
Tolar Reaches Market Capitalization of $2.32 Million


© 2006-2019 Ticker Report